| 0 (0%) | 02-21 15:55 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 223.67 | 1-year : | 261.24 |
| Resists | First : | 191.5 | Second : | 223.67 |
| Pivot price | 184.13 |
|||
| Supports | First : | 179.47 | Second : | 172.05 |
| MAs | MA(5) : | 183.82 |
MA(20) : | 184.54 |
| MA(100) : | 153.34 |
MA(250) : | 128.36 |
|
| MACD | MACD : | 2.9 |
Signal : | 3.9 |
| %K %D | K(14,3) : | 53.9 |
D(3) : | 48.8 |
| RSI | RSI(14): 55.1 |
|||
| 52-week | High : | 191.5 | Low : | 86.98 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ AXSM ] has closed above bottom band by 44.2%. Bollinger Bands are 59.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 186.11 - 187.06 | 187.06 - 187.79 |
| Low: | 179.29 - 180.29 | 180.29 - 181.05 |
| Close: | 182.14 - 183.81 | 183.81 - 185.1 |
Sat, 21 Feb 2026
Lion Street Advisors LLC Buys 5,619 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Fri, 20 Feb 2026
Axsome Therapeutics's Earnings Outlook - Benzinga
Fri, 20 Feb 2026
Axsome Therapeutics, Inc. $AXSM Stock Holdings Lifted by Aberdeen Group plc - MarketBeat
Wed, 18 Feb 2026
Is It Too Late To Consider Axsome Therapeutics (AXSM) After Its Strong Three Year Run? - Yahoo Finance
Wed, 18 Feb 2026
Axsome Therapeutics (AXSM) Valuation After SUNOSI Patent Settlement Extends Generic Entry Timeline - Yahoo Finance
Tue, 17 Feb 2026
Axsome SUNOSI Patent Settlement Clarifies Exclusivity Window And Future Competition - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 50 (M) |
| Shares Float | 43 (M) |
| Held by Insiders | 15.6 (%) |
| Held by Institutions | 77.3 (%) |
| Shares Short | 2,710 (K) |
| Shares Short P.Month | 2,840 (K) |
| EPS | -4.64 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.47 |
| Profit Margin | -41 % |
| Operating Margin | -19.3 % |
| Return on Assets (ttm) | -19.8 % |
| Return on Equity (ttm) | -275.5 % |
| Qtrly Rev. Growth | 63.2 % |
| Gross Profit (p.s.) | 10.22 |
| Sales Per Share | 11.13 |
| EBITDA (p.s.) | -3.73 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -101 (M) |
| Levered Free Cash Flow | -18 (M) |
| PE Ratio | -39.6 |
| PEG Ratio | 0 |
| Price to Book value | 124.97 |
| Price to Sales | 16.5 |
| Price to Cash Flow | -91.75 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|